GlaxoSmithKline PLC — Director's Dealing 2016

Jul 19, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6618E

GlaxoSmithKline PLC

19 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Sir Andrew Witty

b)

Position/status

CEO

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882 

b)

Nature of the transaction

Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£16.285	3.975
£16.285	217.131
£16.285	580.125
£16.285	1,329.326
£16.285	3,988.006
£16.285	5,452.053
£16.285	5,905.210

d)

Aggregated information

Aggregated volume Price

17,475.826

£16.285

e)

Date of the transaction

2016-07-14

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDKLFFQDFLBBX

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'IPp6DsR1fFynWg86oGnIJSAzOzc2DwVw9bq-BM21YBgY0lT8cZmfgRwlqBbEAWPyL0Et3B5q22Vx7dMLlvOtxrlbZGkC9K6L2qqNGhjCJv01:gpQ7_0SYQ0HijrSU3IZr1ZMOf1QjDd1BgezCguTz3YOFc1IQ_gtcSu_hIkSqziOzjcu2o51fL5wytbzNhyuFGoItPpka_YHaqp_RKJ4uyU41'}});//]]>